Latest News About Mpox

Here’s the latest on mpox (monkeypox) based on the most recent public reporting available up to now.

• Global status: The mpox outbreak has evolved from a declared public health emergency in some regions to an ongoing management phase, with focus on vaccination, surveillance, and access to antivirals where needed. WHO and regional health authorities have continued to issue guidance and updated recommendations as case patterns shift.[2][3]

• Vaccines and therapeutics: Several mpox vaccines have received emergency use or full approvals in different jurisdictions, and vaccine stockpiles have been expanded in some regions to support ring-vaccination strategies and outbreak control. There are ongoing efforts to evaluate antivirals and to launch booster trials to bolster population immunity where transmission persists.[1][3][2]

• Regional activity: Africa and parts of Europe have reported ongoing transmission dynamics, with public health agencies maintaining enhanced surveillance, particularly in outbreak-prone settings, sex-network contexts, and among close contacts of confirmed cases. European procurement efforts continue to strengthen orthopoxvirus preparedness, including vaccination options.[3][1]

• Public health guidance: Health authorities have maintained temporary recommendations on testing, vaccination, infection prevention, and risk communication, adapting as new data emerge about transmission routes and clinical outcomes.[2][3]

If you’d like, I can tailor a quick briefing for your location (Johannesburg, Gauteng) with the most relevant local guidance and any travel considerations, or pull the very latest headlines from a specific source. I can also create a short summary you can share with colleagues.

Citations:

• WHO mpox page and outbreak updates.[3]
• Recent mpox vaccine approvals and emergency use guidance.[2]
• Mpox vaccine development and outbreak response coverage.[1]